亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods

肉汤微量稀释 替加环素 微生物学 头孢吡肟 美罗培南 亚胺培南 生物 医学 抗生素 抗生素耐药性 最小抑制浓度
作者
Shu‐Chen Kuo,Mei-Chen Tan,Wei‐Cheng Huang,Han Chieh Wu,Feng-Jui Chen,Yu-Chieh Liao,Huiying Wang,Yih-Ru Shiau,Tsai‐Ling Lauderdale
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:76 (3): 653-658 被引量:16
标识
DOI:10.1093/jac/dkaa499
摘要

Abstract Objectives We aimed to determine susceptibilities of Elizabethkingia spp. to 25 commonly tested and 8 novel antibiotics, and to compare the performance of different susceptibility testing methods. Methods Clinical isolates of Elizabethkingia spp., Chryseobacterium spp. and Flavobacterium spp. collected during 2002–18 (n = 210) in a nationwide surveillance programme in Taiwan were speciated by 16S rRNA sequencing. MICs were determined by broth microdilution. The broth microdilution results of 18 common antibiotics were compared with those obtained by the VITEK 2 automated system. Results Among the Elizabethkingia spp. identified (n = 108), Elizabethkingia anophelis was the most prevalent (n = 90), followed by Elizabethkingia meningoseptica (n = 7) and Elizabethkingia miricola cluster [E. miricola (n = 6), Elizabethkingia bruuniana (n = 3) and Elizabethkingia ursingii (n = 2)]. Most isolates were recovered from respiratory or blood specimens from hospitalized, elderly patients. PFGE showed two major and several minor E. anophelis clones. All isolates were resistant to nearly all the tested β-lactams. Doxycycline, minocycline and trimethoprim/sulfamethoxazole inhibited >90% of Elizabethkingia spp. Rifampin inhibited E. meningoseptica (100%) and E. anophelis (81.1%). Fluoroquinolones and tigecycline were active against E. meningoseptica and E. miricola cluster isolates. Novel antibiotics, including imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam, delafloxacin, eravacycline and omadacycline were ineffective but lascufloxacin inhibited half of Elizabethkingia spp. The very major discrepancy rates of VITEK 2 were >1.5% for ciprofloxacin, moxifloxacin and vancomycin. Major discrepancy rates were >3% for amikacin, tigecycline, piperacillin/tazobactam and trimethoprim/sulfamethoxazole. Conclusions MDR, absence of standard interpretation criteria and poor intermethod concordance necessitate working guidelines to facilitate future research of emerging Elizabethkingia spp.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Amai完成签到,获得积分10
14秒前
34秒前
soft完成签到,获得积分10
43秒前
PPP完成签到,获得积分10
47秒前
FMHChan完成签到,获得积分10
55秒前
ZJX应助个性的绮彤采纳,获得10
1分钟前
1分钟前
1分钟前
医研发布了新的文献求助10
1分钟前
星星发布了新的文献求助10
1分钟前
星星完成签到,获得积分10
1分钟前
chloe完成签到,获得积分10
1分钟前
浮游应助科研通管家采纳,获得10
1分钟前
我是老大应助科研通管家采纳,获得10
1分钟前
完美世界应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
刘金金完成签到,获得积分10
2分钟前
俭朴夜雪完成签到,获得积分10
2分钟前
林白应助小贾爱喝冰美式采纳,获得10
2分钟前
刘金金发布了新的文献求助10
2分钟前
竹青完成签到 ,获得积分10
2分钟前
凡夫俗子完成签到 ,获得积分10
2分钟前
任性的皮皮虾完成签到,获得积分10
2分钟前
2分钟前
修慈发布了新的文献求助10
2分钟前
SCI的李完成签到 ,获得积分10
3分钟前
清秋1001完成签到 ,获得积分10
3分钟前
3分钟前
Miku完成签到,获得积分10
3分钟前
11完成签到,获得积分10
3分钟前
思源应助科研通管家采纳,获得10
3分钟前
浮游应助科研通管家采纳,获得10
3分钟前
浮游应助科研通管家采纳,获得10
3分钟前
科研通AI6应助科研通管家采纳,获得10
3分钟前
Jasper应助科研通管家采纳,获得10
3分钟前
老实验人完成签到,获得积分10
3分钟前
乐乐应助11采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
Performance optimization of advanced vapor compression systems working with low-GWP refrigerants using numerical and experimental methods 500
Constitutional and Administrative Law 500
PARLOC2001: The update of loss containment data for offshore pipelines 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5291397
求助须知:如何正确求助?哪些是违规求助? 4442414
关于积分的说明 13829865
捐赠科研通 4325442
什么是DOI,文献DOI怎么找? 2374255
邀请新用户注册赠送积分活动 1369544
关于科研通互助平台的介绍 1333738